GSK PLC/ GB0009252882 /
5/23/2022 11:13:00 AM | Chg. +0.20 | Volume | Bid11:14:02 AM | Ask11:14:04 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,764.20GBX | +0.01% | 250,644 Turnover(GBP): 4.43 mill. |
1,763.80Bid Size: 16 | 1,764.20Ask Size: 181 | 88.23 bill.GBP | - | - |
GlobeNewswire
3/25
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire
2/28
Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen’s 42nd Annual Health Care Co...
GlobeNewswire
2/28
Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones,...
GlobeNewswire
2/10
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
GlobeNewswire
12/14/2021
Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its...